Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Capital Leases (2019 - 2026)

Apyx Medical filings provide 9 years of Capital Leases readings, the most recent being $12000.0 for Q4 2025.

  • On a quarterly basis, Capital Leases fell 63.64% to $12000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $12000.0, a 63.64% decrease, with the full-year FY2025 number at $12000.0, down 63.64% from a year prior.
  • Capital Leases hit $12000.0 in Q4 2025 for Apyx Medical, down from $18000.0 in the prior quarter.
  • In the past five years, Capital Leases ranged from a high of $107000.0 in Q1 2021 to a low of $12000.0 in Q4 2025.
  • Median Capital Leases over the past 5 years was $45500.0 (2024), compared with a mean of $48250.0.
  • Biggest five-year swings in Capital Leases: crashed 93.66% in 2021 and later skyrocketed 423.08% in 2023.
  • Apyx Medical's Capital Leases stood at $18000.0 in 2021, then soared by 305.56% to $73000.0 in 2022, then decreased by 27.4% to $53000.0 in 2023, then tumbled by 37.74% to $33000.0 in 2024, then crashed by 63.64% to $12000.0 in 2025.
  • The last three reported values for Capital Leases were $12000.0 (Q4 2025), $18000.0 (Q3 2025), and $23000.0 (Q2 2025) per Business Quant data.